Medical Device Cybersecurity Consulting Services

Medical device cybersecurity consulting typically includes cybersecurity risk assessments, secure software documentation support, regulatory strategy, submission readiness reviews, change impact assessments, and post-market governance planning. For connected or software-enabled devices, consultants also help align risk management, software lifecycle records, labeling, and technical documentation with applicable standards and regulator expectations such as FDA, ISO 14971, and IEC 62304.

Cybersecurity is important because regulators increasingly expect manufacturers to show that connected devices are designed, documented, and maintained with security in mind. Weak cybersecurity controls can delay submissions, trigger deficiencies, increase patient safety risk, and create post-market reporting issues. Strong cybersecurity documentation supports safer device performance, clearer risk-benefit justification, and more defensible submissions and audits.

Yes. Cybersecurity consulting for SaMD can cover classification support, regulatory pathway planning, software lifecycle documentation, cybersecurity risk management, intended use alignment, and submission readiness. Because software-based devices often face close scrutiny around architecture, updates, data handling, and risk controls, structured consulting helps ensure the documentation package is complete, traceable, and aligned with regulator expectations.

A submission readiness assessment reviews the device against the actual regulatory pathway you plan to use. That usually includes evaluating technical documentation completeness, software records, risk management integrity, labeling, clinical or performance evidence, and quality system alignment. The result should be a prioritized gap report with remediation actions so your team knows what must be fixed before engaging regulators.

Sometimes they do. Changes to software, connectivity, architecture, labeling, intended use, or risk controls can affect the device's authorized status depending on the market and the significance of the change. A structured change impact assessment helps determine whether the update requires a new 510(k), PMA supplement, notified body involvement, or another regulatory action before implementation.

Relevant standards and frameworks often include ISO 14971 for risk management, IEC 62304 for software lifecycle processes, ISO 13485 for quality systems, and market-specific regulatory guidance such as FDA cybersecurity expectations. The exact mix depends on device type, software functionality, connectivity, and target markets. Effective consulting maps your documentation and controls to the standards most relevant to your submission pathway.

Yes. Post-market cybersecurity support can include complaint and PMS governance, reportability assessments, trend reviews, CAPA linkage, and updates to risk management or technical documentation when new vulnerabilities or field issues emerge. This is especially important for connected devices, where security events may affect safety, performance, and regulatory reporting obligations across multiple markets.

Cybersecurity consulting is especially valuable for medical device manufacturers, SaMD developers, digital health companies, diagnostics firms, and startups preparing for market entry or scaling globally. It is also useful for established companies managing design changes, remediation projects, or post-market obligations. Any organization with software-enabled, networked, or data-handling devices can benefit from stronger cybersecurity compliance planning.